SEARCH BY
| Category | Company |
|---|---|
| Founded | 1896 |
| Sector | Life Science |
| Employees | 100,920 |
| Revenue | 62.4B CHF (2024) |
Roche is a research-focused healthcare company focused on pharmaceuticals and diagnostics. Roche offers differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. It offers diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche was founded in 1896 and is based in Basel, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 32 of 44 |
| Sector: Life Science M&A | 20 of 31 |
| Type: Add-on Acquisition M&A Deals | 29 of 36 |
| State: California M&A | 12 of 16 |
| Country: United States M&A | 20 of 30 |
| Year: 2017 M&A | 4 of 4 |
| Size (of disclosed) | 10 of 31 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-11-17 |
Viewics
San Jose, California, United States Viewics, Inc. is an established market player in business analytics for laboratories. Through expertise and focus on healthcare analytics, Viewics, Inc. delivers proprietary, best-in-class technology for data extraction, cleansing, and transformation that quickly unlock insights, which deliver invaluable operational and financial outcomes, while reducing burden on IT. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-09-28 |
Tusk Therapeutics
Hertfordshire, United Kingdom Tusk Therapeutics Ltd. is a privately held immuno-oncology company focused on discovering and developing therapeutic antibodies that harness the power of the immune system to transform the treatment of cancer. The Company’s lead programme consists of a first-in-class antibody for the depletion of regulatory T-cells, based on the work of Dr. Sergio Quezada. |
Buy | - |
